Home › Drug Codes › NOC Codes › ZYCUBO
HCPCS Unassigned

ZYCUBO

copper histidinate · Sentynl Therapeutics

Login to unlock all benchmarks
Miscellaneous Code ?
J3490
bill until Dec 31, 2026
Permanent Code ?
J7293
effective Jan 1, 2027
WAC ?
Subscribe to view
AWP ?
Subscribe to view
NDCs Listed
1
Subscribe to view

Drug & Product Overview

Permanent Code Descriptor (from Jan 1, 2027) Injection, copper histidinate, 0.01 mg
Miscellaneous Billing Code J3490
FDA Approval Date January 12, 2026
Manufacturer Sentynl Therapeutics
Active Ingredient copper histidinate
Route of Administration Subcutaneous
Dosage Form Injection, Powder, Lyophilized, For Solution

How to Bill ZYCUBO Now

Through December 31, 2026, bill ZYCUBO with J3490, the code for unclassified drugs, and identify the product by its NDC. From January 1, 2027, bill J7293.

Check coverage before you bill

ZYCUBO’s label allows a trained caregiver to give it at home. CMS’s descriptor for J7293 reads “Injection, copper histidinate, 0.01 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)”, so Medicare accepts the code only for doses given under a physician’s direct supervision. Doses given at home are usually billed on the pharmacy benefit instead. See the SAD exclusion lists →

Setting Claim Form Billing Code Notes
Physician office / Part B CMS-1500 / 837P J3490 Only for doses given under a physician’s direct supervision. Enter the drug name, dose and NDC in Item 19 (or the 837P equivalent).
Hospital outpatient (OPPS) UB-04 / 837I C9399 Unclassified drug or biological. Separately payable and priced manually by the MAC.
Required Claim Documentation
Drug name and dosage administered National Drug Code (NDC) of the product given Total quantity administered, in the applicable unit of measure Date the drug was administered

About ZYCUBO

ZYCUBO (copper histidinate) is a subcutaneous injection from Sentynl Therapeutics for Menkes disease in pediatric patients. It was approved by the FDA on January 12, 2026.

ZYCUBO Pricing & NDCs

Package WAC and AWP for each NDC, updated monthly. There's no ASP payment limit until a permanent code takes effect.

NDC Code Package WAC AWP

1 NDC on file. Subscribe to see its package, WAC and AWP, with monthly history.

HCPCS Code Status

As of Nov 5, 2026
Today · through Dec 31, 2026
J3490
Unclassified drugs
Effective Jan 1, 2027
J7293
Injection, copper histidinate, 0.01 mg

J3490 claims for ZYCUBO with dates of service on or after January 1, 2027 will be denied. Confirm coding with your payer before billing.

ZYCUBO Clinical Information

Treated Diseases & Conditions
Menkes disease in pediatric patients

Try Pro free for 7 daysUpgrade to ProAdd Analytics and full history with Pro

Pro includes:

  • ASP, WAC and AWP for every drug
  • NDC package pricing
  • 10+ years of price history
  • Side-by-side Analytics in the Comparative Report

Card required · cancel anytime

Frequently Asked Questions

What HCPCS code is used for ZYCUBO?

J3490 (unclassified drugs) for dates of service through December 31, 2026, and its permanent code J7293 from January 1, 2027, for doses given under a physician’s direct supervision. Hospital outpatient claims use C9399 until the permanent code takes effect.

Can J7293 be billed when a caregiver gives ZYCUBO at home?

Not to Medicare. CMS’s descriptor says the code is not for use when the drug is self-administered. Home doses are usually billed on the pharmacy benefit.

What NDC goes on a ZYCUBO claim?

The NDC of the package you administered. Subscribers can see ZYCUBO’s NDCs with package, WAC and AWP.

Where can I find the full prescribing information?